it is in a class of drugs known as podophyllotoxin derivatives and slows the growth of cancer cells in the body teniposide is used for the treatment of a number of cancer types in children in the us it is approved for the second line therapy of acute lymphocytic leukemia all in combination with other antineoplastic drugs in europe it is also approved for the treatment of hodgkin s lymphoma generalized malignant lymphoma reticulocyte sarcoma acute leukaemia primary brain tumours glioblastoma ependymoma astrocytoma bladder cancer neuroblastoma and other solid tumours in children the medication is injected though a vein and burns if it leaks under the skin it can be used in combination with other anticancer drugs the drug is contraindicated during pregnancy and lactation in patients with severe liver or kidney impairment or severely impaired haematopoiesis teniposide when used with other chemotherapeutic agents for the treatment of all results in severe bone marrow suppression other common side effects include gastrointestinal toxicity hypersensitivity reactions and reversible alopecia no systematic interaction studies are available the enzyme inducers phenobarbital and phenytoin have been found to lower its blood plasma concentrations theoretically possible interactions include increased plasma concentrations when combined with sodium salicylate